Dr Heng Phon Too
received his undergraduate training in Biochemistry, Imperial College of Science & Technology, UK. He then continued with his PhD training in a joint research project in Imperial College, Institute of Ophthalmology and West Minister Hospital (Lond). He further his training in the Medical Research Council, Cambridge (UK), where he was a Procter & Gamble Fellow. He then moved to the Department of Anesthesiology and Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School where he was a recipient of the Merck Sharpe Dohme Academic Development Fellowship. Currently, he is an Associate Professor in the Department of Biochemistry and an adjunct to the Department of Chemical & Biomolecular Engineering, National University Singapore. He is also an adjunct scientist in the Bioprocess Technological Institute, A*STAR. He was both a Fellow and Co-chair of the Singapore Massachusetts Institute of Technology Alliance (Molecular Engineering of Biological & Chemical Systems programme; Chemical & Pharmaceutical Engineering programme).
In recent years, he was funded by Roche Diagnostics (USA & Asia Pacific) and National Institute of Health (USA) to develop qPCR assays for infectious diseases. He is an awardee of a Commercialisation of Technology grant and GAP funding by A*STAR and has founded a spin-off focusing on microRNA detection. A*STAR continues to fund the initiative on microRNA for diagnostics, predictive and companion diagnostics. He has intellectual property protections on technological platforms with various research departments and with Massachusetts Institute of Technology, USA.